Advertisement

Clinicopathologic features between different viral epidemic outbreaks involving the skin

      Abstract

      The current coronavirus disease 2019 pandemic has exceeded any epidemiologic prevision, but increasing information suggests some analogies with the major viral outbreaks of the last century. A general warning has been issued on the possibility that coinfections can make differential diagnosis and treatment difficult, especially in tropical countries. Some reports have pointed out that the presence of high Dengue antibodies can give a false-negative result for severe acute respiratory syndrome coronavirus 2. Mucocutaneous manifestations are very frequent, with an apparent overlap among different pathogens. A strong clinicopathologic correlation, however, may provide some clues to address the differential. Waiting for laboratory and instrumental results, the timing and distribution of skin lesions is often pathognomonic. Histopathologic findings characterize certain reaction patterns and provide insights on pathogenetic mechanisms. Unfortunately, skin assessments, especially invasive exams such as biopsy, are less important in severely ill patients. A literature review was performed to collect information from other epidemics to counteract what has become the most frightening disease of our time.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Priyadarsini SL
        • Suresh M
        • Huisingh D.
        What can we learn from previous pandemics to reduce the frequency of emerging infectious diseases like COVID-19?.
        Glob Transit. 2020; 2: 202-220
        • Ellwanger JH
        • Chies JA.
        Emergent diseases in emergent countries: we must study viral ecology to prevent new epidemics.
        Braz J Infect Dis. 2016; 20: 403-404
        • Billington J
        • Deschamps I
        • Erck SC
        • et al.
        Developing vaccines for SARS-CoV-2 and future epidemics and pandemics: applying lessons from past outbreaks.
        Health Secur. 2020; 18: 241-249
        • Petersen E
        • Koopmans M
        • Go U
        • et al.
        Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
        Lancet Infect Dis. 2020; 20: e238-e244
      1. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020. Accessed March 20, 2020. 2020.

      2. European Centre for Disease Prevention and Control. Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – sixth update. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-sixth-update-Outbreak-of-novel-coronavirus-disease-2019-COVID-19.pdf. Accessed March 20, 2020.

      3. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) 2019. Available at: https://www.cdc.gov/coronavirus/2019-ncov/index.html. Accessed March 20, 2020.

      4. Coronavirus Resource Center of the John Hopkins University. Available at: https://coronavirus.jhu.edu/map.html. Accessed March 20, 2020.

        • Keighley CL
        • Saunderson RB
        • Kok J
        • Dwyer DE.
        Viral exanthems.
        Curr Opin Infect Dis. 2015; 28: 139-150
        • Criado PR
        • Pagliari C
        • Carneiro FRO
        • Quaresma JAS.
        Lessons from dermatology about inflammatory responses in Covid-19.
        Rev Med Virol. 2020; 30: e2130
        • Drago F
        • Ciccarese G
        • Gasparini G
        • et al.
        Contemporary infectious exanthems: an update.
        Future Microbiol. 2017; 12: 171-193
        • Peeri NC
        • Shrestha N
        • Rahman MS
        • et al.
        The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?.
        Int J Epidemiol. 2020; 49: 717-726
        • Petrosillo N
        • Viceconte G
        • Ergonul O
        • Ippolito G
        • Petersen E.
        COVID-19, SARS and MERS: are they closely related?.
        Clin Microbiol Infect. 2020; 26: 729-734
        • Contini C
        • Di Nuzzo M
        • Barp N
        • et al.
        The novel zoonotic COVID-19 pandemic: an expected global health concern.
        J Infect Dev Ctries. 2020; 14: 254-264
        • Rongioletti F
        SARS-CoV, Mers-CoV and COVID-19: what differences from a dermatological viewpoint?.
        J Eur Acad Dermatol Venereol. 2020; 34: e581-e582
        • Xie M
        • Chen Q.
        Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV.
        Int J Infect Dis. 2020; 94: 119-124
        • Chen Y
        • Liu Q
        • Guo D.
        Emerging coronaviruses: genome structure, replication, and pathogenesis.
        J Med Virol. 2020; 92: 418-423
        • Gorbalenya AE
        • Baker SC
        • Baric RS
        • et al.
        The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.
        Nat Microbiol. 2020; 5: 536-544
        • Chan JF
        • Kok KH
        • Zhu Z
        • et al.
        Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.
        Emerg Microbes Infect. 2020; 9: 221-236
        • Xu Z
        • Shi L
        • Wang Y
        • et al.
        Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
        Lancet Respir Med. 2020; 8: 420-422
        • Kakodkar P
        • Kaka N
        • Baig M.
        A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19).
        Cureus. 2020; 12: e7560
        • Qin C
        • Zhou L
        • Hu Z
        • et al.
        Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China.
        Clin Infect Dis. 2020; 71: 762-768
      5. World Health Orgaization, Weekly Epidemiological Update. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200928-weekly-epi-update.pdf?sfvrsn=9e354665_6. Accessed March 20, 2020.

      6. Matar S, Oulès B, Sohier P, et al. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature [e-pub ahead of print]. J Eur Acad Dermatol Venereol. 2020; 34:e686-e689. doi: 10.1111/jdv.16775.Epub 2020 Jul 20.:10.1111/jdv.16775.

        • Guan WJ
        • Ni ZY
        • Hu Y
        • et al.
        Clinical characteristics of coronavirus disease 2019 in China.
        N Engl J Med. 2020; 382: 1708-1720
      7. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective [e-pub ahead of print]. J Eur Acad Dermatol Venereol. 2020; 34:e212-e213. doi: 10.1111/jdv.16387.

      8. Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 ;183:71-77. :10.1111/bjd.19163.

        • Zhao Q
        • Fang X
        • Pang Z
        • Zhang B
        • Liu H
        • Zhang F
        COVID-19 and cutaneous manifestations: a systematic review.
        J Eur Acad Dermatol Venereol. 2020; 34 (10.1111/jdv.16778): 2505-2510
        • Freeman EE
        • McMahon DE
        • Lipoff JB
        • et al.
        The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries.
        J Am Acad Dermatol. 2020; 83 (10.1016/j.jaad.2020.06.1016): 1118-1129
        • Wollina U
        • Karadağ AS
        • Rowland-Payne C
        • Chiriac A
        • Lotti T
        Cutaneous signs in COVID-19 patients: a review.
        Dermatol Ther. 2020; 33 (10.1111/dth.13549): e13549.doi
        • Criado PR
        • Abdalla BMZ
        • de Assis IC
        • van Blarcum de Graaff Mello C
        • Caputo GC
        • Vieira IC.
        Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.
        Inflamm Res. 2020; 69: 745-756
        • Marzano AV
        • Cassano N
        • Genovese G
        • Moltrasio C
        • Vena GA
        Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.
        Br J Dermatol. 2020; 183: 431-442https://doi.org/10.1111/bjd.19264
        • Kaya G
        • Kaya A
        • Saurat JH.
        Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: review of the literature.
        Dermatopathology (Basel). 2020; 7: 3-16
        • Seirafianpour F
        • Sodagar S
        • Pour Mohammad A
        • et al.
        Cutaneous manifestations and considerations in COVID-19 pandemic: a systematic review.
        Dermatol Ther. 2020; 33e13986https://doi.org/10.1111/dth.13986
        • Riphagen S
        • Gomez X
        • Gonzalez-Martinez C
        • Wilkinson N
        • Theocharis P
        • et al.
        Hyperinflammatory shock in children during COVID-19 pandemic.
        Lancet. 2020; 395: 1607-1608
        • Bapst T
        • Romano F
        • Müller M
        • Rohr M.
        Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme.
        BMJ Case Rep. 2020; 13e236986
        • Verdoni L
        • Mazza A
        • Gervasoni A
        • et al.
        An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.
        Lancet. 2020; 395: 1771-1778
        • Recalcati S
        • Barbagallo T
        • Frasin LA
        • et al.
        Acral cutaneous lesions in the time of COVID-19.
        J Eur Acad Dermatol Venereol. 2020; 34: e346-e347https://doi.org/10.1111/jdv.16533
        • Piccolo V
        • Neri I
        • Filippeschi C
        • et al.
        Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.
        J Eur Acad Dermatol Venereol. 2020; 34: e291-e293https://doi.org/10.1111/jdv.16526
        • de Masson A
        • Bouaziz JD
        • Sulimovic L
        • et al.
        Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France.
        J Am Acad Dermatol. 2020; 83: 667-670
        • El Hachem M
        • Diociaiuti A
        • Concato C
        • et al.
        A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
        J Eur Acad Dermatol Venereol. 2020; 34: 2620-2629https://doi.org/10.1111/jdv.16682
        • Locatelli AG
        • Robustelli Test E
        • Vezzoli P
        • et al.
        Histologic features of long-lasting chilblain-like lesions in a pediatric COVID-19 patient.
        J Eur Acad Dermatol Venereol. 2020; 34: e365-e368https://doi.org/10.1111/jdv.16617
      9. Kolivras A, Dehavay F, Delplace D, et al. Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings. JAAD Case Rep.2020; 18;6:489-492doi:10.1016/j.jdcr.2020.04.011.

        • Hamming I
        • Timens W
        • Bulthuis ML
        • Lely AT
        • Navis G
        • van Goor H.
        Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus.
        J Pathol. 2004; 203: 631-637
        • Colmenero I
        • Santonja C
        • Alonso-Riaño M
        • et al.
        SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
        Br J Dermatol. 2020; 183: 729-737
        • Roca-Ginés J
        • Torres-Navarro I
        • Sánchez-Arráez J
        • et al.
        Assessment of acute acral lesions in a case series of children and adolescents during the COVID-19 pandemic.
        JAMA Dermatol. 2020; 156: 992-997https://doi.org/10.1001/jamadermatol.2020.2340
        • Caselli D
        • Chironna M
        • Loconsole D
        • et al.
        No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.
        Br J Dermatol. 2020; 183: 784-785https://doi.org/10.1111/bjd.19349
        • Herman A
        • Peeters C
        • Verroken A
        • et al.
        Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic.
        JAMA Dermatol. 2020; 156: 998-1003https://doi.org/10.1001/jamadermatol.2020.2368
        • Docampo-Simón A
        • Sánchez-Pujol MJ
        • Juan-Carpena G
        • et al.
        Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.
        J Eur Acad Dermatol Venereol. 2020; 34: e445-e447https://doi.org/10.1111/jdv.16665
        • Llamas-Velasco M
        • Muñoz-Hernández P
        • Lázaro-González J
        • et al.
        Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient.
        Br J Dermatol. 2020; 183: 591-593https://doi.org/10.1111/bjd.19222
        • Suarez-Valle A
        • Fernandez-Nieto D
        • Diaz-Guimaraens B
        • Dominguez-Santas M
        • Carretero I
        • Perez-Garcia B
        Acro-ischemia in hospitalized COVID-19 patients.
        J Eur Acad Dermatol Venereol. 2020; 34: e455-e457https://doi.org/10.1111/jdv.16592
        • Balestri R
        • Termine S
        • Rech G
        • Girardelli CR
        Late onset of acral necrosis after SARS-CoV-2 infection resolution.
        J Eur Acad Dermatol Venereol. 2020; 34: e448-e449https://doi.org/10.1111/jdv.16668
        • Andersen MB
        • Lund ML
        • Jacobsn S
        • Kümle T
        • Simonsen S
        • Ravn P.
        [Acral ischaemia with multiple microthromboses and imminent gangrene in a 73-year-old woman with COVID-19].
        Ugeskr Laeger. 2020; 182 ([in Danish])V05200379
      10. Caputo V, Schroeder J, Rongioletti F. A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19. J Eur Acad Dermatol Venereol. 2020; 34:e579-e581.doi:10.1111/jdv.16737.

        • Magro C
        • Mulvey JJ
        • Berlin D
        • et al.
        Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases.
        Transl Res. 2020; 220: 1-13https://doi.org/10.1016/j.trsl.2020.04.007
        • Zhang Y
        • Cao W
        • Jiang W
        • et al.
        Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
        J Thromb Thrombolysis. 2020; 50: 580-586https://doi.org/10.1007/s11239-020-02182-9
        • Zhang Y
        • Cao W
        • Xiao M
        • et al.
        [Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
        Zhonghua Xue Ye Xue Za Zhi. 2020; 41 ([in Chinese]): E006
        • Schnapp A
        • Abulhija H
        • Maly A
        • et al.
        Introductory histopathological findings may shed light on COVID-19 paediatric hyperinflammatory shock syndrome.
        J Eur Acad Dermatol Venereol. 2020; 34: e665-e667https://doi.org/10.1111/jdv.16749
        • Fernandez-Nieto D
        • Ortega-Quijano D
        • Jimenez-Cauhe J
        • et al.
        Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital.
        Clin Exp Dermatol. 2020; 45: 872-875https://doi.org/10.1111/ced.14277
        • Llamas-Velasco M
        • Chicharro P
        • Rodríguez-Jiménez P
        • et al.
        Reply to “Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital”: pseudo herpetic Grover disease seems to appear in patients with COVID-19 infection.
        Clin Exp Dermatol. 2020; 34: e559-e561https://doi.org/10.1111/ced.14305
      11. Mahé A, Birckel E, Merklen C, et al. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not 'varicella-like'. J Eur Acad Dermatol Venereol. 2020; 34:e559-e561.doi:10.1111/jdv.16706, accessed XX.

      12. Xue X, Mi Z, Wang Z, Pang Z, Liu H, Zhang F. High Expression of ACE2 on keratinocytes reveals skin as a potential target for SARS-CoV-2. J Invest Dermatol. 2021;141: 206-209.e1. doi:10.1016/j.jid.2020.05.087, accessed XX.

        • Jamiolkowski D
        • Mühleisen B
        • Müller S
        • Navarini AA
        • Tzankov A
        • Roider E
        SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report.
        Lancet. 2020; : 598-599.https://doi.org/10.1016/S0140-6736(20)31754-2
      13. Santonja C, Heras F, Núñez L, Requena L. COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient. Br J Dermatol. 2021; 93:161-162. :10.1111/bjd.19338.

        • Shank GD.
        Insights from unusual aspects of the 1918 influenza pandemic.
        Travel Med Infect Dis. 2015; 13: 217-222
        • Murray CJ
        • Lopez AD
        • Chin B
        • Feehan D
        • Hill KH.
        Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis.
        Lancet. 2006; 368: 2211-2218
        • Smith G
        • Bahl J
        • Vijaykrisna D
        • et al.
        Dating the emergence of pandemic influenza viruses.
        Proc Natl Acad Sci U S A. 2009; 106: 11709-11712
        • Worobey M
        • Han GZ
        • Rambaut A.
        Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus.
        Proc Natl Acad Sci U S A. 2014; 111: 8107-8112
        • Shanks GD
        • Brundage JF.
        Pathogenic responses among young adults during the 1918 influenza pandemic.
        Emerg Infect Dis. 2012; 18: 201-207
        • Gagnon A
        • Acosta JE
        • Madrenas J
        • Miller MS.
        Is antigenic sin always “original?” Re-examining the evidence regarding circulation of a human H1 influenza virus immediately prior to the 1918 Spanish Flu.
        PLoS Pathog. 2015; 11e1004615
        • Skowronski DM
        • De Serres G
        • Crowcroft NS
        • et al.
        Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.
        PLoS Med. 2010; 7e1000258
        • Duque V
        • Vaz J
        • Mota V
        • Morais C
        • Da Cunha S
        • Meliço-Silvestre A
        Clinical manifestations of pandemic (H1N1) 2009 in the ambulatory setting.
        J Infect Dev Ctries. 2011; 5: 658-663
        • Muir R
        • Wilson GH.
        Observations on influenza and its complications.
        Br Med J. 1919; 1: 3-5
        • Abrahams A
        • Hallows N
        • French H.
        Influenzo-pneumococcal and influenzo-streptococcal septicaemia: epidemic influenzal pneumonia of highly fatal type and its relation to purulent bronchitis.
        Lancet. 1919; 193: 1e11
        • Macpherson WG
        • Herringham W
        • Elliott T
        • Balfour A.
        History of the Great War based on official documents. Medical services. Diseases of the war. 1. His Majesty's Stationary Office, London, UK1922
        • Taubenberger JK
        • Morens DM.
        The pathology of influenza virus infections.
        Ann Rev Path. 2008; 3: 499-522
        • Brem WV
        • Bolling GE
        • Casper EJ.
        Pandemic “influenza” and secondary pneumonia at Camp Fremont, Calif.
        JAMA. 1918; 71: 2138-2144
        • Miah MA
        • Husna A
        Coinfection, coepidemics of COVID-19, and dengue in dengue-endemic countries: a serious health concern.
        J Med Virol. 2021; : 161-162.https://doi.org/10.1002/jmv.26269
        • Joob B
        • Wiwanitkit V.
        COVID-19 can present with a rash and be mistaken for dengue.
        J Am Acad Dermatol. 2020; 82: e177
      14. Lokida D, Lukman N, Salim G, et al. Diagnosis of COVID-19 in a dengue-endemic area. Am J Trop Med Hyg. 2020; 103:1220-1222:10.4269/ajtmh.20-0676.

        • Bastos MLA
        • Araújo RMO
        • Oliveira DS
        • Cavalcante ANM
        • Silva Junior GBD
        Thrombotic thrombocytopenic purpura associated with dengue and chikungunya virus coinfection: case report during an epidemic period.
        Rev Inst Med Trop Sao Paulo. 2018; 60: e48
        • Epelboin L
        • Bidaud B
        • Mosnier E
        • et al.
        Fatal case of chikungunya and concomitant thrombotic thrombocytopenic purpura in French Guiana during air flight medical evacuation.
        J Travel Med. 2017; 24https://doi.org/10.1093/jtm/tax028
        • Deepahjali S
        • Naik RR
        • Mailankody S
        • Kalaimani S
        • Kadhiravan T.
        Dengue virus infection triggering thrombotic thrombocytopenic purpura in pregnancy.
        Am J Trop Med Hyg. 2015; 93: 1028-1030
        • Ferreira ML
        • Cavalcanti CG
        • Coelho CA
        • Mesquita SD.
        Manifestações neurológicas de dengue: estudo de 41 casos [Neurological manifestations of dengue: study of 41 cases].
        Arq Neuropsiquiatr. 2005; 63 ([in Portuguese]): 488-493
        • Teixeira MG
        • Barreto ML.
        Diagnosis and management of dengue.
        BMJ. 2009; 339: b4338
        • Albuquerque PL
        • Silva GB
        • Júnior Diógenes SS
        • Silva HF
        Dengue and aplastic anemia—a rare association.
        Travel Med Infect Dis. 2009; 7: 118-120
        • Ehelepolar ND
        • Gunawadhan MB
        • Sudusinghe TN
        • Sooriyaarachchi SK
        • Manchanayake SP
        • Kalupahana KL.
        A dengue infection without bleeding manifestation in an adult with immune thrombocytopenic purpura.
        Trop Med Health. 2016; 44: 36
        • Itoda I
        • Masuda G
        • Suganuma A
        • et al.
        Clinical features of 62 imported cases of dengue fever in Japan.
        Am J Trop Med Hyg. 2006; 75: 470-474
        • Azfar NA
        • Malik LM
        • Jamil A
        • et al.
        Cutaneous manifestations in patients of dengue fever.
        J Pak Assoc Dermatol. 2012; 22: 320-324
        • Thomas EA
        • John M
        • Kanish B.
        Mucocutaneous manifestations of dengue fever.
        Indian J Dermatol. 2010; 55: 79-85
        • Chadwick D
        • Arch B
        • Wilder-Smith A
        • Paton N.
        Distinguishing dengue fever from other infections on the basis of simple clinical and laboratory features: application of logistic regression analysis.
        J Clin Virol. 2006; 35: 147-153
        • Mahboob A
        • Iqbal Z
        • Javed R
        • et al.
        Dermatological manifestations of dengue fever.
        J Ayub Med Coll Abbottabad. 2012; 24: 52-54
        • Huang HW
        • Tseng HC
        • Lee CH
        • Chuang HY
        • Lin SH.
        Clinical significance of skin rash in dengue fever: a focus on discomfort, complications, and disease outcome.
        Asian Pacific J Trop Med. 2016; 9: 713-718
        • Martyn-Simmons CL
        • Powell SE
        • Sudhanva M
        • Selim AG
        • Creamer D
        • Pearson IC.
        A florid skin rash in a returning traveller.
        Clin Exp Dermatol. 2007; 32: 779-781
        • Wu SJ
        • Grouard-Vogel G
        • Sun W
        • et al.
        Human skin Langerhans cells are targets of dengue virus infection.
        Nat Med. 2000; 6: 816-820
        • Saadiah S
        • Sharifah BI
        • Robson A
        • Greaves MW.
        Skin histopathology and immunopathology are not of prognostic value in dengue haemorrhagic fever.
        Br J Dermatol. 2008; 158: 836-837
        • Booth KK
        • Terrell DR
        • Versely SK
        • George JN.
        Systemic infections mimicking thrombotic thrombocytopenic purpura.
        Am J Hematol. 2011; 86: 743-751
        • Patterson J
        • Sammon M
        • Dengue Garg M.
        Zika and Chikungunya: emerging arboviruses in the New World.
        West J Emerg Med. 2016; 17: 671-679
        • Rezza G
        • Nicoletti L
        • Angelini R
        • et al.
        Infection with chikungunya virus in Italy: an outbreak in a temperate region.
        Lancet. 2007; 370: 1840-1846
        • Haby MM
        • Pinart M
        • Elias V
        • Reveiz L.
        Prevalence of asymptomatic Zika virus infection: a systematic review.
        Bull World Health Organ. 2018; 96: 402
      15. Kumar R, Sharma MK, Jain SK, Yadav SK, Singhal AK. Cutaneous manifestations of chikungunya fever: observations from an outbreak at a tertiary care hospital in southeast Rajasthan, India. Indian Dermatol Online J.2017;8:336-342.

        • Kumar S
        • Agrawal G
        • Wazir S
        • et al.
        Experience of perinatal and neonatal chikungunya virus (CHIKV) infection in a tertiary care neonatal centre during outbreak in North India in 2016: a case series.
        J Trop Pediatr. 2019; 65: 169-175
        • Barr KL
        • Vaidhyanathan V.
        Chikungunya in infants and children: is pathogenesis increasing?.
        Viruses. 2019; 11: 294
        • Muñoz CM
        • Castillo JO
        • Salas D
        • et al.
        [Atypical mucocutaneous manifestations in neonates and infants with chikungunya fever in the municipalities of Cúcuta, Los Patios and Villa del Rosario, Norte de Santander, Colombia, 2014].
        Biomedica. 2016; 36 ([in Spanish]): 368-377
        • Inamadar AC
        • Palit A
        • Sampagavi VV
        • Raghunath S
        • Deshmukh NS.
        Cutaneous manifestations of chikungunya fever: observations made during a recent outbreak in south India.
        Int J Dermatol. 2008; 47: 154-159
        • Townson H
        • Nathan MB.
        Resurgence of chikungunya.
        Trans R Soc Trop Med Hyg. 2008; 102: 308-309
        • Riyaz N
        • Riyaz A
        • Rahima
        • et al.
        Cutaneous manifestations of chikungunya during a recent epidemic in Clicut, north Kerala, south India.
        Indian J Dermatol Venereol Leprol. 2010; 76: 671-676
        • Seetharam KA
        • Sridevi K
        • Vidyasagar P.
        Cutaneous manifestations of chikungunya fever.
        Indian Pediatr. 2012; 49: 51-53
        • Shivakumar V
        • Rajendra O
        • Rajkumar V
        • Rajasekhar TV.
        Unusual facial melanosis in viral fever.
        Indian J Dermatol. 2007; 52: 116-117
        • Fernandes AIV
        • Souza JR
        • Silva AR
        • Cruz SBSC
        • Castellano LRC.
        Immunoglobulin therapy in a patient with severe chikungunya fever and vesiculobullous lesions.
        Front Immunol. 2019; 10: 1498
        • El Sayed F
        • Dhaybi R
        Chikungunya associated with cutaneous ulcerations.
        Clin Exp Dermatol. 2008; 33: 463-464
        • Singal A
        • Pandhi D.
        Isolated nail pigmentation associated with chikungunya: a hitherto unreported manifestation.
        Skin Appendage Disord. 2018; 4: 312-314
        • Matusali G
        • Colavita F
        • Bordi L
        • et al.
        Tropism of the chikungunya virus.
        Viruses. 2019; 11: 175
        • Kumar V
        • Jain R
        • Kumar A
        • et al.
        Chikungunya fever presenting as life threatening thrombotic thrombocytopenic purpura.
        J Assoc Physicians India. 2017; 11765: 96-100
        • Spiteri G
        • Sudre B
        • Septfons A
        • Beauté J
        The European Zika surveillance Network. Surveillance of Zika virus infection in the EU/EEA, June 2015 to January 2017.
        Euro Surveill. 2017; 22: 17-00254
        • Counotte MJ
        • Kim CR
        • Wang J
        • et al.
        Sexual transmission of Zika virus and other flaviviruses: a living systematic review.
        PLoS Med. 2018; 15e1002611
        • Hastings AK
        • Fikrig E.
        Zika Virus and sexual transmission: a new route of transmission for mosquito-borne Flaviviruses.
        Yale J Biol Med. 2017; 90: 325-330
        • Tang B
        • Zhou WK
        • Xiao YN
        • Wu JH.
        Implication of sexual transmission of Zika on dengue and Zika outbreaks.
        Math Biosci Eng. 2019; 16: 5092-5113
        • Kim CR
        • Counotte M
        • Bernstein K
        • et al.
        Sexual Transmission of Zika virus Expert Meeting participants. Investigating the sexual transmission of Zika virus.
        Lancet Glob Health. 2018; 6: e24-e25
        • Farahnik B
        • Beroukhim K
        • Blattner CM
        • Young 3rd., J
        Cutaneous manifestations of the Zika virus.
        J Am Acad Dermatol. 2016; 74: 1286-1287
        • Joob B
        • Wiwanitkit V.
        Cutaneous manifestations of Zika.
        J Cutan Med Surg. 2020; 24: 220
        • Ramos W
        • Luna M
        • Alarcón T
        • et al.
        Cutaneous manifestations of Zika in Peru.
        J Cutan Med Surg. 2020; 24: 33-40
        • Paniz-Mondolfi AE
        • Blohm GM
        • Hernandez-Perez M
        • et al.
        Cutaneous features of Zika virus infection: a clinicopathological overview.
        Clin Exp Dermatol. 2019; 44: 13-19
        • Nkoghe D
        • Leroy EM
        • Toung-Mve M
        • Gonzalez JP.
        Cutaneous manifestations of filovirus infections.
        Int J Dermatol. 2012; 51: 1037-1043
        • Gates B.
        The next epidemic—lessons from Ebola.
        N Engl J Med. 2015; 372: 1381-1384
        • Coltart CE
        • Lindsey B
        • Ghinai I
        • Johnson AM
        • Heymann DL.
        The Ebola outbreak, 2013-2016: old lessons for new epidemics.
        Philos Trans R Soc Lond B Biol Sci. 2017; 37220160297
        • Kucharski AJ
        • Edmunds WJ.
        Case fatality rate for Ebola virus disease in west Africa.
        Lancet. 2014; 384: 1260
        • Leroy EM
        • Kumulungui B
        • Pourrut X
        • et al.
        Fruit bats as reservoirs of Ebola virus.
        Nature. 2005; 438: 575-576
        • Blattner CM
        • Mortazie MB
        • Murase JE.
        Cutaneous manifestations of the Ebola virus.
        Dermatol Online J. 2015; 21 (13030/qt7429f9vf)
        • Bwaka MA
        • Bonnet MJ
        • Calain P
        • et al.
        Ebola haemorrhagic fever in Kikwit, Democratic Republic of Congo: clinical observations in 103 patients.
        J Infect Dis. 1999; 1: S1-S7
        • Zaki SR
        • Shieh W-J
        • Greer PW
        • et al.
        A novel immunohistochemical assay for detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever.
        J Infect Dis. 1999; 179: S36-S47
        • Ling L
        • Joynt GM
        • Lipman J
        • Constantin JM
        • Joannes-Boyau O
        COVID-19: a critical care perspective informed by lessons learnt from other viral epidemics.
        Anaesth Crit Care Pain Med. 2020; 39: 163-166